Myriad Genetics Inc. Strategy SWOT and Corporate Finance Report Report Updated 15102018 Prices from USD $175

Myriad Genetics, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 15102018] Prices from USD $175

08:37 EST 16 Nov 2018 | BioPortfolio Report Blog

Myriad Genetics, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Myriad Genetics, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Myriad Genetics, Inc. Myriad or 'the company' is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company operates a CLIAcertified laboratory facility in Salt Lake City, Utah to perform most of the molecular diagnostic tests; a CLIAcertified laboratory in South San Francisco, California; a single laboratory facility in Munich, Germany to perform the international molecular diagnostic tests; and a CLIAcertified laboratory facility in Austin, Texas. The company has its operations in the US and Europe. Myriad is headquartered in Salt Lake City, Utah.


Scope


Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis

An indepth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments

Intelligence on Myriad Genetics, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Myriad Genetics, Inc.'s business structure, strategy and prospects.

More From BioPortfolio on "Myriad Genetics, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 15102018] Prices from USD $175"